ADIA — Adia Nutrition, Inc.

OTC · Materials · Chemicals · CIK 1160420 ·
Last close
$0.12
Market Cap
$11.33M
52W High
$0.19
52W Low
$0.10
ADV30
13,683
Next earnings
Adia Med Inc operates as a clinical-stage regenerative medicine company. The company offers products and services focused on stem cell therapies, regenerative medicine treatments, and clinical research in areas such as aesthetics, orthopedics, and autoimmune diseases. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in June 2026. Adia Med Inc is based in Winter Park, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 176,275 67,577 -151,920 -162,525 776,868 136,716 1,197,067
Dec 2025 63,363 -51,790 -212,439 -219,358 594,826 79,392 852,500
Sep 2025 364,391 211,185 84,396 75,572 776,215 153,870 846,781
Jun 2025 150,437 18,223 -128,049 -135,459 705,595 109,223 855,233

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-203,090
Investing CF
$-34,751
Financing CF
$337,094
CapEx
$-22,298
Dividends Paid
Buybacks
EPS Diluted TTM
$0.00
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-16,136,007
Inventory
$109,750
Receivables
$79,610
ST Investments
$6,450
EBIT TTM
$-404,869
Pretax Income TTM
$-441,770
Interest Exp TTM
$36,901
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,172,258
EBITDA
$-207,044
Free Cash Flow
Enterprise Value
$12,348,584
Total Cash
$128,115
Total Debt
$993,777
Shares Out
94,404,696
Trailing EPS
$0.00
Book Value
$-0.01
ROE
ROA
Div Yield

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 700,508 -366,492 -395,464 594,826 852,500 -179,228
Dec 2024 6,380 -174,749 -181,067 666,181 640,641 -335,476

Peers — same industry

TickerNameMarket CapLastDaily %
PURE PURE BIOSCIENCE, INC. $11.70M $0.09
BIOT INSTINCT BIO TECHNICAL CO HOLDINGS INC. $11.89M $0.41
MTEX MANNATECH INC $12.45M $6.45
BNET BION ENVIRONMENTAL TECHNOLOGIES INC $9.76M $0.17
CFOO China Foods Holdings Ltd. $13.45M $0.66

News headlines (Yahoo Finance, 1h cache)

Adia Med Inc. Engages Lucosky Brookman LLP as Legal Counsel for Planned NASDAQ Uplisting
2026-08-24 12:00 · Yahoo
Adia Med Delivers Record Q2 Results: $485K Revenue, First Net Profit, and Nearly Matches Full-Year 2025 Revenue in First Half
2026-08-13 16:07 · Yahoo
Adia Med Partners with Full Sail University; CEO Larry Powalisz to Present Company and Explore Student Assistance with SEO, Social Media, and Marketing
2026-08-11 12:00 · Yahoo
Adia Med to Host Dinner for Physicians at Christner's Steakhouse on August 5 to Discuss Clinical Studies and Collaboration Opportunities
2026-08-05 20:30 · Yahoo
Adia Med Completes Phase 1 and Formally Launches Phase 2 of Autism Spectrum Disorder Clinical Study
2026-07-29 10:00 · Yahoo
Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate Website
2026-07-15 13:30 · Yahoo
Adia Med's Rise, Highlighting 2.5 Years of Growth Toward NASDAQ
2026-07-13 13:00 · Yahoo
Adia Nutrition to Trade as Adia Med Inc. After Lightning-Fast FINRA Review
2026-07-09 12:00 · Yahoo
Adia Nutrition Inc. Enters FINRA Home Stretch for Corporate Name Change to Adia Med Inc.
2026-07-07 14:19 · Yahoo
Adia Med Finds Another Unicorn
2026-06-30 16:49 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.